Shares of Catalyst Prescribed drugs Inc.
inched 0.70% larger to $4.34 Friday, on what proved to be an all-around favorable buying and selling session for the inventory market, with the NASDAQ Composite Index
rising 0.07% to 13,874.46 and the Dow Jones Industrial Common
rising 0.00% to 31,494.32. This was the inventory’s third consecutive day of features. Catalyst Prescribed drugs Inc. closed $0.93 in need of its 52-week excessive ($5.27), which the corporate achieved on February 21st.
The inventory outperformed a few of its rivals Friday, as Johnson & Johnson
fell 1.67% to $162.98, Pfizer Inc.
fell 0.35% to $34.44, and Abbott Laboratories
fell 1.89% to $123.04. Buying and selling quantity (1.1 M) remained 823,205 under its 50-day common quantity of two.Zero M.